Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 12 | 2022 | 38 | 3.110 |
Why?
|
| Ultrasonography | 7 | 2020 | 77 | 3.080 |
Why?
|
| Mandible | 5 | 2018 | 6 | 2.710 |
Why?
|
| Humans | 39 | 2024 | 14537 | 1.580 |
Why?
|
| HIV Infections | 9 | 2024 | 5097 | 1.490 |
Why?
|
| Psychotic Disorders | 3 | 2018 | 7 | 1.370 |
Why?
|
| Asthma | 2 | 2022 | 33 | 1.340 |
Why?
|
| Point-of-Care Systems | 3 | 2020 | 91 | 1.340 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2021 | 25 | 1.300 |
Why?
|
| Spermatic Cord Torsion | 2 | 2019 | 2 | 1.270 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2018 | 4 | 1.210 |
Why?
|
| Adult | 16 | 2023 | 5913 | 0.990 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 1422 | 0.950 |
Why?
|
| Intensive Care Units | 3 | 2024 | 66 | 0.940 |
Why?
|
| Male | 14 | 2022 | 6754 | 0.840 |
Why?
|
| South Africa | 15 | 2023 | 7596 | 0.810 |
Why?
|
| Poisoning | 1 | 2022 | 3 | 0.810 |
Why?
|
| Pesticides | 1 | 2022 | 4 | 0.800 |
Why?
|
| Length of Stay | 2 | 2021 | 43 | 0.780 |
Why?
|
| Patient Discharge | 1 | 2022 | 27 | 0.770 |
Why?
|
| Inosine Monophosphate | 1 | 2021 | 3 | 0.770 |
Why?
|
| Critical Illness | 2 | 2024 | 44 | 0.770 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 47 | 0.760 |
Why?
|
| Manikins | 1 | 2021 | 2 | 0.760 |
Why?
|
| Central Nervous System Stimulants | 1 | 2021 | 4 | 0.750 |
Why?
|
| Emergency Medical Technicians | 1 | 2021 | 2 | 0.750 |
Why?
|
| Infection Control | 2 | 2020 | 31 | 0.750 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 29 | 0.730 |
Why?
|
| Insecticides | 1 | 2022 | 135 | 0.710 |
Why?
|
| Hand Sanitizers | 1 | 2020 | 1 | 0.710 |
Why?
|
| Protective Clothing | 1 | 2020 | 3 | 0.710 |
Why?
|
| Hand Disinfection | 1 | 2020 | 9 | 0.710 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 3 | 0.710 |
Why?
|
| Urolithiasis | 1 | 2020 | 1 | 0.690 |
Why?
|
| Medication Adherence | 1 | 2021 | 151 | 0.680 |
Why?
|
| Electricity | 1 | 2019 | 1 | 0.680 |
Why?
|
| Power Plants | 1 | 2019 | 1 | 0.680 |
Why?
|
| Health Facilities | 1 | 2019 | 40 | 0.660 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2018 | 1 | 0.620 |
Why?
|
| HTLV-I Infections | 1 | 2018 | 1 | 0.620 |
Why?
|
| Hypercalcemia | 1 | 2018 | 2 | 0.610 |
Why?
|
| Female | 12 | 2022 | 9103 | 0.610 |
Why?
|
| Intestinal Volvulus | 1 | 2018 | 2 | 0.610 |
Why?
|
| Meningitis | 1 | 2018 | 26 | 0.610 |
Why?
|
| Simulation Training | 1 | 2018 | 1 | 0.600 |
Why?
|
| Urologic Surgical Procedures | 1 | 2018 | 1 | 0.600 |
Why?
|
| Models, Anatomic | 1 | 2018 | 2 | 0.600 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 3 | 0.600 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 5 | 0.600 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 7 | 0.600 |
Why?
|
| Heart Arrest | 1 | 2018 | 9 | 0.600 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 7 | 0.590 |
Why?
|
| Urinary Bladder | 3 | 2023 | 3 | 0.590 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 9 | 0.590 |
Why?
|
| Sarin | 1 | 2017 | 1 | 0.570 |
Why?
|
| Shock | 1 | 2017 | 4 | 0.570 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 25 | 0.560 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 8 | 0.560 |
Why?
|
| Fluid Therapy | 1 | 2017 | 25 | 0.560 |
Why?
|
| Hemodynamics | 1 | 2017 | 32 | 0.550 |
Why?
|
| Anti-Retroviral Agents | 1 | 2021 | 551 | 0.550 |
Why?
|
| Chin | 1 | 2016 | 1 | 0.550 |
Why?
|
| Health Resources | 1 | 2017 | 66 | 0.550 |
Why?
|
| HIV-1 | 2 | 2021 | 1260 | 0.500 |
Why?
|
| Retrospective Studies | 5 | 2022 | 799 | 0.490 |
Why?
|
| Starvation | 1 | 2012 | 1 | 0.410 |
Why?
|
| Tertiary Care Centers | 3 | 2020 | 80 | 0.380 |
Why?
|
| Prospective Studies | 3 | 2021 | 1160 | 0.380 |
Why?
|
| Hospital Mortality | 2 | 2021 | 95 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 2 | 2023 | 127 | 0.340 |
Why?
|
| Acute Disease | 2 | 2021 | 105 | 0.330 |
Why?
|
| Hospitalization | 2 | 2022 | 418 | 0.310 |
Why?
|
| Disease Progression | 2 | 2018 | 154 | 0.290 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 563 | 0.280 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 217 | 0.280 |
Why?
|
| Risk Factors | 2 | 2022 | 1475 | 0.280 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 385 | 0.270 |
Why?
|
| Time Factors | 2 | 2018 | 507 | 0.260 |
Why?
|
| Viral Load | 2 | 2021 | 819 | 0.250 |
Why?
|
| Middle Aged | 5 | 2023 | 3601 | 0.240 |
Why?
|
| Adolescent | 3 | 2022 | 2985 | 0.230 |
Why?
|
| Mobile Applications | 1 | 2023 | 12 | 0.220 |
Why?
|
| Physicians | 1 | 2023 | 31 | 0.220 |
Why?
|
| Telemedicine | 1 | 2023 | 25 | 0.210 |
Why?
|
| Pelvis | 1 | 2023 | 5 | 0.210 |
Why?
|
| Young Adult | 2 | 2022 | 2498 | 0.210 |
Why?
|
| Sepsis | 2 | 2024 | 102 | 0.210 |
Why?
|
| Carbamates | 1 | 2022 | 12 | 0.200 |
Why?
|
| Organophosphates | 1 | 2022 | 9 | 0.200 |
Why?
|
| Metered Dose Inhalers | 1 | 2022 | 3 | 0.200 |
Why?
|
| Administration, Inhalation | 1 | 2022 | 5 | 0.200 |
Why?
|
| Critical Care | 2 | 2024 | 52 | 0.200 |
Why?
|
| Hospitals | 1 | 2022 | 103 | 0.190 |
Why?
|
| ROC Curve | 1 | 2021 | 51 | 0.190 |
Why?
|
| Hand | 1 | 2021 | 5 | 0.190 |
Why?
|
| Pressure | 1 | 2021 | 6 | 0.190 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 18 | 0.190 |
Why?
|
| Odds Ratio | 1 | 2021 | 133 | 0.190 |
Why?
|
| Clinical Audit | 1 | 2020 | 3 | 0.180 |
Why?
|
| Prognosis | 1 | 2021 | 199 | 0.180 |
Why?
|
| Quality Improvement | 1 | 2020 | 34 | 0.170 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 30 | 0.170 |
Why?
|
| Artifacts | 1 | 2020 | 3 | 0.170 |
Why?
|
| Guideline Adherence | 1 | 2020 | 43 | 0.170 |
Why?
|
| Foodborne Diseases | 1 | 2019 | 6 | 0.170 |
Why?
|
| Cooking | 1 | 2019 | 7 | 0.170 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2019 | 1 | 0.170 |
Why?
|
| Testis | 1 | 2019 | 2 | 0.170 |
Why?
|
| Orchiectomy | 1 | 2019 | 6 | 0.170 |
Why?
|
| Sanitation | 1 | 2019 | 17 | 0.170 |
Why?
|
| Communication | 1 | 2019 | 57 | 0.160 |
Why?
|
| Environmental Exposure | 1 | 2019 | 45 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 71 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2019 | 656 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 104 | 0.160 |
Why?
|
| Photophobia | 1 | 2018 | 1 | 0.160 |
Why?
|
| Substance Abuse Detection | 1 | 2018 | 2 | 0.160 |
Why?
|
| Hallucinations | 1 | 2018 | 2 | 0.160 |
Why?
|
| Headache | 1 | 2018 | 7 | 0.160 |
Why?
|
| Spinal Puncture | 1 | 2018 | 4 | 0.160 |
Why?
|
| Fever | 1 | 2018 | 26 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 63 | 0.150 |
Why?
|
| Urinalysis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 61 | 0.150 |
Why?
|
| Cystostomy | 1 | 2018 | 1 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 10 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 96 | 0.150 |
Why?
|
| Hypercapnia | 1 | 2017 | 1 | 0.150 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 1 | 0.150 |
Why?
|
| Positive-Pressure Respiration | 1 | 2017 | 2 | 0.150 |
Why?
|
| Bronchodilator Agents | 1 | 2017 | 7 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 188 | 0.150 |
Why?
|
| Anesthetics, Local | 1 | 2017 | 6 | 0.150 |
Why?
|
| Diazepam | 1 | 2017 | 1 | 0.140 |
Why?
|
| Muscarinic Antagonists | 1 | 2017 | 1 | 0.140 |
Why?
|
| Chemical Terrorism | 1 | 2017 | 1 | 0.140 |
Why?
|
| Mass Casualty Incidents | 1 | 2017 | 1 | 0.140 |
Why?
|
| Atropine | 1 | 2017 | 2 | 0.140 |
Why?
|
| Anticonvulsants | 1 | 2017 | 13 | 0.140 |
Why?
|
| Personal Protective Equipment | 1 | 2017 | 16 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 151 | 0.140 |
Why?
|
| Journal Impact Factor | 1 | 2017 | 2 | 0.140 |
Why?
|
| Aged | 2 | 2023 | 1740 | 0.140 |
Why?
|
| Bibliometrics | 1 | 2017 | 5 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 106 | 0.140 |
Why?
|
| Mouth | 1 | 2016 | 8 | 0.140 |
Why?
|
| Global Health | 1 | 2018 | 193 | 0.140 |
Why?
|
| Dental Care for Disabled | 1 | 1996 | 1 | 0.130 |
Why?
|
| Mouthwashes | 1 | 1996 | 3 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 1996 | 10 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2016 | 2 | 0.130 |
Why?
|
| Animals | 1 | 2019 | 1081 | 0.130 |
Why?
|
| HIV Seropositivity | 1 | 2018 | 265 | 0.130 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 411 | 0.130 |
Why?
|
| Anatomic Variation | 1 | 2015 | 1 | 0.130 |
Why?
|
| Coinfection | 1 | 2018 | 276 | 0.130 |
Why?
|
| Incidence | 1 | 2018 | 685 | 0.130 |
Why?
|
| Radiography | 1 | 2015 | 80 | 0.130 |
Why?
|
| HIV | 1 | 2017 | 380 | 0.120 |
Why?
|
| Developing Countries | 1 | 2017 | 400 | 0.110 |
Why?
|
| Prevalence | 1 | 2017 | 1192 | 0.110 |
Why?
|
| Medical Records | 1 | 2013 | 23 | 0.110 |
Why?
|
| Somalia | 1 | 2012 | 2 | 0.100 |
Why?
|
| Warfare | 1 | 2012 | 3 | 0.100 |
Why?
|
| Refugees | 1 | 2012 | 10 | 0.100 |
Why?
|
| Poverty Areas | 1 | 2012 | 20 | 0.100 |
Why?
|
| Child | 2 | 2023 | 2242 | 0.060 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2023 | 3 | 0.060 |
Why?
|
| Rupture, Spontaneous | 1 | 2023 | 4 | 0.050 |
Why?
|
| Rupture | 1 | 2023 | 3 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2024 | 195 | 0.050 |
Why?
|
| Health Personnel | 1 | 2023 | 231 | 0.050 |
Why?
|
| Hospital Administration | 1 | 2020 | 3 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2020 | 26 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 52 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 149 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 370 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 296 | 0.040 |
Why?
|
| Periodontal Index | 1 | 1996 | 1 | 0.030 |
Why?
|
| Gingivitis | 1 | 1996 | 2 | 0.030 |
Why?
|
| Oral Hygiene | 1 | 1996 | 2 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 1996 | 40 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 1996 | 272 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 2013 | 3 | 0.030 |
Why?
|
| Medical Audit | 1 | 2013 | 26 | 0.030 |
Why?
|